Advances of pharmacological therapies in lipodystrophy syndromes: current evidence and future directions

There is currently no cure for lipodystrophy syndromes. Emerging therapies are being investigated to expand therapeutic options and improve long-term outcomes of this complex disorder.

Authors

Institutions

Publication Details

Journal
Expert Review of Endocrinology & Metabolism
Published
2025-11-02
DOI
https://doi.org/10.1080/17446651.2025.2574318
Citations
2
Primary Topic
Nuclear Structure and Function
Type
article
Field-Weighted Citation Impact
1.61
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Advances of pharmacological therapies in lipodystrophy syndromes: current evidence and future directions

Özge Besci, Merve Çelik Güler, Elif A Oral, Maria Cristina Foss‐Freitas
2 citations
Expert Review of Endocrinology & Metabolism
Nuclear Structure and Function
1.61
article

Advances of pharmacological therapies in lipodystrophy syndromes: current evidence and future directions

Özge Besci, Merve Çelik Güler, Elif A Oral, Maria Cristina Foss‐Freitas
article en
2 citations

Abstract

There is currently no cure for lipodystrophy syndromes. Emerging therapies are being investigated to expand therapeutic options and improve long-term outcomes of this complex disorder.

Expert Review of Endocrinology & MetabolismVol. 20(6)
University of Michigan (US)
Openalex Percentile: Top 14%
Nuclear Structure and Function
1.61
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.